CD69 and head and neck squamous cell carcinoma: Further analyses of various T cell subsets revealed that an increased frequency of CTLs from patients with HNSCC expressed CD69 and CD71 (Fig. 2C and D) and Th cells from the same patients displayed an increased percentage of CD69, CD71 and CD98 (Fig. 2E–G).